Robert A Wise, M.D.

Headshot of Robert A Wise
  • Medical Director Pulmonary Function Laboratory, Johns Hopkins Asthma & Allergy Center
  • Professor of Medicine
Male

Expertise

Chronic Obstructive Pulmonary Disease (COPD), Pulmonary and Critical Care Medicine ...read more

Research Interests

Critical care medicine; Emphysema; Scleroderma; Pulmonary medicine; Asthma; Lung-volume reduction surgery; COPD ...read more

Locations

Johns Hopkins Bayview Medical Center

5501 Hopkins Bayview Circle
Asthma and Allergy Center
Baltimore, MD 21224
Phone: 410-550-5688
Johns Hopkins Bayview Medical Center - Google Maps

Background

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research.

Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease.

...read more

Titles

  • Medical Director Pulmonary Function Laboratory, Johns Hopkins Asthma & Allergy Center
  • Professor of Medicine
  • Instructor of Radiology and Radiological Science

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MD; Medicine; Harvard Medical School (1971)

Residencies

  • Medicine; University of Michigan Health System (1977)

Fellowships

  • Environmental Health Sciences; Johns Hopkins Bloomberg School of Public Health (1980)
  • Respiratory Therapy; Johns Hopkins University School of Medicine (1980)

Board Certifications

  • American Board of Internal Medicine (Internal Medicine) (1976)
  • American Board of Internal Medicine (Pulmonary Disease) (1980)

Research & Publications

Research Summary

Dr. Wise and his team conduct clinical trials to study chronic obstructive lung diseases (COPD) and asthma.  This includes pharmacologic agents, behavioral interventions, and devices. 

Clinical Trials

Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients. (ASCENT COPD)


Losartan for treatment of Emphysema (LEEP)


Zinc Gluconate for Chronic Cough (ZICO)

Contact for Research Inquiries

Johns Hopkins Asthma and Allergy Center
5501 Hopkins Bayview Circle
Baltimore, MD 21224 map

Is this you? Edit Profile
back to top button